Best Folate for Pregnancy: A Clear Guide
Folate is one of the most important nutrients before and during pregnancy, and one of the most confusing. Folic acid, methylfolate, Quatrefolic, levomefolic acid: the labels can feel impossible to decode, and there are strong opinions on all sides. This guide cuts through the noise. Below you will find a straightforward breakdown of what each form is, what health authorities actually recommend, what dose carries the neural tube claim, and how to decode the label in front of you. For a full deep-dive into the clinical evidence, see our complete article on folic acid vs methylfolate in pregnancy.
Key Takeaways
- Folate (vitamin B9) is critical before and during early pregnancy, particularly for supporting healthy neural tube development in the first weeks of fetal growth
- Folic acid is the synthetic form with the strongest clinical trial evidence for supporting neural tube defect (NTD) risk reduction, and is the form referenced in official guidelines
- Methylfolate is the biologically active form your cells actually use, and it appears on labels under many different names
- The standard recommended dose to support neural tube health is 400 mcg (0.4 mg) of folic acid daily, starting at least one month before conception and continuing through the first trimester
- Women with elevated risk factors may be prescribed up to 5 mg per day. This is a conversation to have with your healthcare provider
- MTHFR gene variants affect how efficiently you convert folic acid, but at standard doses most people still achieve adequate folate status
- Some prenatal supplements combine folic acid and methylfolate to support multiple folate pathways
What Is Folate and Why Does It Matter So Much in Early Pregnancy?
Folate is the umbrella term for a family of water-soluble B vitamins (vitamin B9) essential for DNA synthesis, cell division, and healthy fetal development. It is particularly critical in the first 28 days after conception, when the neural tube (the embryonic structure that becomes the brain and spinal cord) is forming and closing.
Because this happens so early, often before a woman even knows she is pregnant, building adequate folate stores before conception genuinely matters. Supplementing after a positive test may already be late for this specific window.
When you see "folate" on a supplement label, it usually refers to one of two specific forms: folic acid or methylfolate. These are genuinely different, and the distinction is worth understanding.
Folic Acid: What It Is and What the Research Actually Shows
Folic acid is a synthetic, oxidised form of vitamin B9 used in supplements and food fortification. It does not occur naturally in food. Once ingested, folic acid must be converted through a series of enzymatic steps into the biologically active form (5-MTHF) that your cells can use.
Folic acid has the strongest evidence base of any folate form in pregnancy. Large, well-designed clinical trials have shown that folic acid supplementation before and during early pregnancy significantly helps reduce the risk of neural tube defects (NTDs) including spina bifida and anencephaly (MRC Vitamin Study Research Group, 1991; Czeizel and Dudas, 1992). This is why it is the form specifically referenced in health authority guidelines globally.
What dose carries the neural tube defect claim?
The standard recommendation from Australian guidelines and international health authorities is 400 mcg (0.4 mg) of folic acid daily, ideally starting at least one month before conception and continuing through the first trimester (Australian Pregnancy Care Guidelines, 2023; WHO, 2016).
For women with elevated NTD risk (including those who have had a previous NTD-affected pregnancy, are taking certain anticonvulsant medications, or have relevant metabolic conditions), a higher dose of 5 mg (5,000 mcg) per day is typically recommended. This is assessed case by case and should always be discussed with your GP, midwife, or obstetrician.
Methylfolate: The Active Form and Every Name It Goes By
Methylfolate (formally 5-methyltetrahydrofolate, or 5-MTHF) is the biologically active form of folate. It is the form that circulates in your blood and the form your cells directly use. Unlike folic acid, methylfolate does not require enzymatic conversion. Your body can utilise it straight away.
Methylfolate has become increasingly common in premium prenatal supplements. But it appears on product labels under a range of names, which is where most people get lost.
Every Methylfolate Name You Might See on a Label
| Label Name | What It Is |
|---|---|
| 5-MTHF | Shortened scientific name for 5-methyltetrahydrofolate |
| 5-methyltetrahydrofolate | Full scientific name for the biologically active form of folate |
| L-methylfolate | Common supplement name for the same active compound |
| Levomefolic acid | Another name for 5-MTHF, sometimes used in clinical or European formulations |
| 6S-5-methyltetrahydrofolic acid | The precise stereochemical name (the 6S configuration is the biologically active one) |
| Quatrefolic | A patented, branded form of 5-MTHF (glucosamine salt) known for high stability and bioavailability |
| Metafolin | Another branded form (calcium salt of L-methylfolate), developed by Merck |
All of these names refer to the same biologically active folate compound. If you see any of them on a label, you are looking at methylfolate.
What About MTHFR?
The MTHFR gene produces an enzyme involved in converting folic acid into its active form. Some people carry variants of this gene, particularly C677T, that reduce the enzyme's efficiency, meaning the conversion process is slower.
MTHFR variants are genuinely common. Around 30 to 50% of the population carry at least one copy of the C677T variant, with approximately 10% of Caucasians and Asians carrying two copies (homozygous), which can reduce enzyme activity by 60 to 70% (Wilcken et al., 2003).
Here is the important nuance: research suggests that most people with MTHFR variants still achieve adequate folate status at standard supplementation doses of 400 mcg per day (Crider et al., 2011). MTHFR is not irrelevant, but it also does not automatically mean folic acid is ineffective for you, or that you need dramatically higher doses. If you have known MTHFR variants or specific concerns, speak with your healthcare provider or a practitioner experienced in preconception health.
For a detailed breakdown of MTHFR variants, prevalence, and what the evidence actually says about supplementation strategies, see our full article: Folic Acid vs Methylfolate in Pregnancy: The Full Science.
Folic Acid vs Methylfolate: Side-by-Side
| Folic Acid | Methylfolate (5-MTHF) | |
|---|---|---|
| What it is | Synthetic form, requires conversion in the body | Bioactive form, used directly by cells |
| NTD prevention evidence | Strong, supported by multiple large clinical trials | Not yet tested in NTD-specific clinical trials |
| Requires MTHFR conversion? | Yes | No |
| Recommended by health authorities? | Yes. 400 mcg/day is the standard recommendation | Not specifically, but often recommended alongside folic acid |
| Occurs naturally in food? | No, only in supplements and fortified foods | Yes, present as food folate (though in a structurally different form) |
| Common in supplements? | Very common, standard in most prenatals | Increasingly common in premium formulations |
What Do Health Authorities Actually Recommend?
Australian and international health authorities (including the NHMRC, Australian Pregnancy Care Guidelines, RACGP, WHO, and the NHS) consistently recommend folic acid as the form to supplement in pregnancy, at a minimum of 400 mcg per day.
This recommendation is anchored in the clinical trial evidence base, which was built on folic acid specifically. There are currently no large-scale clinical trials demonstrating that methylfolate supplementation reduces NTD risk to the same degree. This is not because methylfolate is ineffective, but because those trials have not yet been conducted.
That does not mean methylfolate has no place in prenatal supplementation. Many practitioners recommend it alongside folic acid, particularly for women with MTHFR variants or those who prefer to supplement with active forms. But if you are asking what form carries the official health claim and the strongest evidence: 400 mcg of folic acid per day remains the answer.
So What Is the Best Folate for Pregnancy?
For most women: folic acid at 400 mcg per day is the evidence-based foundation, because this is what the neural tube defect prevention research is built on, and what every major health authority recommends. Starting at least one month before conception (and ideally three months prior) gives your body time to build adequate stores.
Adding methylfolate, in any of its forms, is a reasonable choice and increasingly common in premium prenatal formulas. A dual-folate supplement that covers both folic acid and an active methylfolate form supports multiple metabolic pathways without sacrificing the evidence-backed baseline.
The practical summary:
- A supplement with 400 mcg folic acid meets the evidence-based recommendation
- A supplement that also contains methylfolate (as Quatrefolic, L-methylfolate, Metafolin, or another form) adds coverage of the active folate pathway
- If you have specific risk factors, MTHFR variants, or are taking medications that interact with folate metabolism, speak with your healthcare provider before choosing a dose or form
Complete Support is formulated with both folic acid and Quatrefolic (a highly bioavailable form of methylfolate), designed to help support healthy folate status across the preconception and pregnancy window. The iron-free variant, Complete Support Sensitive, provides methylfolate as the sole folate source for those who prefer an iron-free formulation.
All content and media on the Mother Natal website are created and published online for informational purposes only. It is not intended to substitute professional medical advice and should not be relied on as health or personal advice.
Frequently Asked Questions
What is the recommended dose of folate for pregnancy? Health authorities including the Australian Pregnancy Care Guidelines and the WHO recommend at least 400 mcg (0.4 mg) of folic acid daily, starting at least one month before conception and continuing through the first trimester. Women with elevated risk factors may be advised to take up to 5 mg per day. Your healthcare provider can advise on the right dose for your circumstances.
When should I start taking folate for pregnancy? Ideally, at least one month before trying to conceive, though three months pre-conception is often cited as optimal to build adequate stores. The neural tube closes around day 28 after conception, usually before most women know they are pregnant, which is why starting supplementation before conception matters.
Is L-methylfolate the same as methylfolate? Yes. L-methylfolate, levomefolic acid, 5-MTHF, Quatrefolic, and Metafolin all refer to the same biologically active form of folate. The different names reflect different chemical notations, salt forms, or brand names, but they are the same active compound.
What is Quatrefolic and how does it differ from folic acid? Quatrefolic is a patented, branded form of 5-methyltetrahydrofolate (5-MTHF), the biologically active form of folate. Unlike folic acid, it does not require enzymatic conversion and is used by the body directly. Folic acid has the stronger clinical evidence base for reducing NTD risk. Many supplements include both forms to cover different metabolic pathways.
Should I take methylfolate if I have an MTHFR gene variant? MTHFR variants reduce your efficiency at converting folic acid into its active form, but research suggests most people with these variants still achieve adequate folate status at standard doses (400 mcg per day). Some practitioners do recommend methylfolate supplementation for those with MTHFR variants, particularly homozygous C677T. Speak with your healthcare provider or a naturopath experienced in preconception health for personalised guidance.
Can I get enough folate from food alone during pregnancy? Food folate, found in leafy greens, legumes, eggs, and fortified foods, contributes meaningfully to your intake, but health authorities consistently recommend supplementing with folic acid in addition to a folate-rich diet. Food folate has lower and more variable bioavailability than supplemental forms, and meeting the full recommended intake through food alone is difficult for most women during preconception and early pregnancy.
Is there a difference between "folate" and "folic acid" on a supplement label? Yes. "Folate" is the general term for vitamin B9. "Folic acid" on a label refers specifically to the synthetic oxidised form used in supplements and fortified foods. Any variation of methylfolate (L-methylfolate, 5-MTHF, Quatrefolic, Metafolin, levomefolic acid) refers to the biologically active form. A label will typically specify which form is used, and it is worth checking.
Why do health authorities still recommend folic acid when methylfolate is the active form? Because the clinical trial evidence base for reducing neural tube defect risk was built specifically on folic acid supplementation. The landmark trials establishing this benefit used folic acid, not methylfolate. This does not mean methylfolate is ineffective, only that the large-scale NTD prevention trials have not been conducted with methylfolate. Until that evidence exists, health authorities continue to recommend folic acid as the form with the proven track record.
How much folate does a prenatal supplement typically contain? Standard prenatal supplements typically contain 400 to 800 mcg of folate, most commonly as folic acid. Premium formulations increasingly include methylfolate in addition to or alongside folic acid. Complete Support contains 400 mcg folic acid plus 100 mcg Quatrefolic methylfolate, for a total of 500 mcg of folate per serve.
References
Australian Pregnancy Care Guidelines (2023). Periconceptional folic acid supplementation. Australian Government Department of Health and Aged Care. Available at: https://www.health.gov.au/resources/pregnancy-care-guidelines
Czeizel, A.E. and Dudas, I. (1992) 'Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation', New England Journal of Medicine, 327(26), pp. 1832–1835.
Crider, K.S., Bailey, L.B. and Berry, R.J. (2011) 'Folic acid food fortification: its history, effect, concerns, and future directions', Nutrients, 3(3), pp. 370–384.
MRC Vitamin Study Research Group (1991) 'Prevention of neural tube defects: results of the Medical Research Council Vitamin Study', The Lancet, 338(8760), pp. 131–137.
National Health and Medical Research Council (NHMRC) (2014). Nutrient Reference Values for Australia and New Zealand: Folate. Canberra: NHMRC. Available at: https://www.eatforhealth.gov.au/nutrient-reference-values/nutrients/folate
Wilcken, B., et al. (2003) 'Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide', Journal of Medical Genetics, 40(8), pp. 619–625.
World Health Organization (2016). WHO Recommendations on Antenatal Care for a Positive Pregnancy Experience. Geneva: WHO. Available at: https://www.who.int/publications/i/item/9789241549912